HJLI Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 spal. 2021 @ 07:00):

Stats
Dzisiejszy wolumen	221 867
Średni wolumen	777 480
Kapitalizacja rynkowa	98.32M
EPS	$-0.310 ( Q1 \| 2024-05-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 0
ATR14	$0.491 (4.73%)

AEMD -4.56%

AFIB -12.68%

AHCO -1.50%

AHPI 0.00%

ALGN -1.08%

ANIK 2.11%

APEN 0.00%

APYX 0.75%

ARAY -3.57%

ATEC -4.88%

AXDX -1.71%

AXGN 5.20%

AXNX 0.05%

AZYO 2.05%

BBLG -1.62%

BIOL 20.00%

BJDX 0.14%

BMRA -1.07%

BRKR -2.88%

BSGM -2.88%

BWAY -3.46%

CERS -1.45%

CFMS 0.44%

CLPT 0.37%

CODX -0.01%

CSII 0.15%

CTKB 0.54%

CTSO 7.04%

CUTR -0.33%

CVRX -5.50%

DCTH -2.28%

DXCM -1.62%

DYNT -3.96%

EAR -4.10%

ECOR -2.33%

EDAP -2.94%

ESTA -5.06%

FONR 0.02%

HJLI -1.98%

HSDT -2.52%

HSKA 0.00%

HYPR 4.69%

IART -1.24%

ICAD -0.38%

ICCM -2.54%

IINN -11.59%

INGN -1.60%

INMD -1.78%

IRIX -2.77%

IRMD -1.08%

IRTC -2.59%

ISO 0.00%

ITMR 0.00%

KIDS -1.84%

LHDX 0.00%

LIVN -0.20%

LNSR -0.37%

LUCD -2.98%

LUNG -3.31%

MASS -7.38%

MDGS 10.28%

MOTS -7.82%

MOVE 1.09%

MSON 0.00%

NAOV 4.91%

NARI 2.72%

NMRD 33.33%

NNOX -1.25%

NPCE -1.59%

NTUS 0.00%

NURO 0.81%

NUVA -2.24%

NUWE -4.65%

NVCN 0.00%

NVNO -2.67%

OBLN -5.86%

OFIX -1.96%

OM -3.90%

PACB -7.69%

PAVM 4.44%

PETV -32.69%

PODD -2.37%

PRCT 0.39%

PROF 2.13%

QIPT -2.17%

QTRX -4.35%

RCEL -2.02%

RPID 2.80%

RSLS 1.36%

RWLK 6.07%

RXST -2.81%

SGHT -5.40%

SIBN -2.01%

SIEN -18.69%

SILK -0.13%

SINT -3.33%

SOLY 0.00%

SRDX -0.19%

SRGA 0.00%

SRTS -5.98%

SWAV 0.00%

TBIO 7.95%

TCMD -3.18%

TELA -1.49%

THMO -14.29%

TIVC -1.22%

TLIS -2.22%

TMCI -1.95%

TMDI 0.00%

TMDX 0.04%

TNDM -3.73%

TNON 14.02%

UFPT 5.28%

VERO -2.75%

VIVE 0.00%

VMD -2.14%

VRAY 0.00%

VREX -2.85%

VVOS 3.60%

XAIR 5.40%

XENT 0.00%

ZIMV -0.55%

Insider Trading

Date	Person	Action	Amount	type
2021-05-18	Berman Robert Andrew	Buy	3 000	Common Stock, $0.00001 par value
2020-07-18	Duhay Francis	Buy	62 500	Common Stock
2020-07-18	Duhay Francis	Buy	100 000	Stock Option
2019-06-07	Biodyne Holding, S.a.	Sell	684 813	Common Stock

INSIDER POWER
0.00
Last 4 transactions
Buy: 165 500 \| Sell: 684 813

Wolumen Korelacja

Długi: 0.03 (neutral)

Krótki: 0.15 (neutral)

Signal:(69.18) Neutral

Hancock Jaffe Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje
MYT	-0.831

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hancock Jaffe Korelacja - Waluta/Towar

-0.78
( moderate negative )

-0.73
( moderate negative )

-0.80
( strong negative )

-0.04
( neutral )

0.65
( weak )

-0.11
( neutral )

Hancock Jaffe Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2023
Przychody:	$0
Zysk brutto:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2022
Przychody:	$0
Zysk brutto:	$-525 000 (0.00 %)
EPS:	$-2.16

FY	2020
Przychody:	$4 252.00
Zysk brutto:	$4 252.25 (100.00 %)
EPS:	$-0.0106

Financial Reports:

No articles found.

Hancock Jaffe Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Hancock Jaffe

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.